Petra Šinigoj

  • Citations Per Year
Learn More
Routine laboratory monitoring is currently not recommended in patients receiving dabigatran despite its considerable variation in plasma concentration. However, in certain clinical situations, measurements of the dabigatran effect may be desirable. We aimed to assess the variability of dabigatran trough and peak concentration and explore the potential(More)
We hypothesized that in a normal healthy population changes in several ECG parameters together might reliably characterize the functional age of the heart. Data from 377 healthy subjects (209 men, 168 women, aged 4 to 75 years) were included in the study. In all subjects, ECG recordings (resting 5-minute 12-lead high fidelity ECG) were evaluated via custom(More)
BACKGROUND Direct oral anticoagulant dabigatran was first introduced as a fixed-dose drug without routine coagulation monitoring, but current recommendations suggest that diluted thrombin time can be used to estimate plasma drug level. The aim of this study was to assess a diluted thrombin time assay based on the same thrombin reagent already used for(More)
  • 1